Microdosing LSD for Health & Longevity - Quick Reference Sheet

Microdosing LSD for Health & Longevity

Created on 09/29/2026 – Quick Reference based on Evidence Review created using AI4L + evidence-mcp / Sonnet 5.5 – Audit

Microdosing LSD is repeated use of a hallucinogenic drug at doses too small to cause noticeable effects, pursued for steadier mood, sharper focus and a more resilient aging brain. Controlled studies show brief effects, not lasting gains; no benefit reaches the highest evidence level. Best-supported findings are side effects: anxiety, physical discomfort, small blood pressure rises, slightly reduced attention control. Whether effects reflect the drug or expectation remains open. (Full Review)

Protocol

Dose
10 µg
Standard community protocol; trials used 5-26 µg
Schedule
Every third day
One dosing day, two rest days; other trials: twice weekly or every fourth day
Duration
6 weeks
14 doses in the home-dosing trial; other trials ran 21 days to 8 weeks
Time to effect
Sleep
Night after dosing
Longer sleep in one six-week trial; not replicated or tested in women or older adults
Mood and well-being
Dosing days
Brief lifts in some trials but not others; no measure changed at six weeks
Acute effects
About 1.1 hours
Onset after 10 µg; peak near 2.5 hours, ends near 5 hours

Benefits

Contraindications
  • Personal or first-degree family history of a psychotic disorder
  • Bipolar disorder or any past manic episode
  • Taking lithium
  • Resting blood pressure above 140/90 mmHg
  • History of seizure disorder, stroke or cardiovascular illness
  • Known heart-valve disease
  • Pregnancy, breastfeeding or planned pregnancy
  • Substance use disorder within the past 12 months
  • Suicidal ideation or behavior within the past 6-12 months
  • Age under 18
Key Interactions
  • Serotonergic antidepressants (fluoxetine, paroxetine, sertraline, trazodone)
  • Tricyclic antidepressants (amitriptyline, imipramine)
  • 5-HT2A blockers (ketanserin, risperidone, olanzapine)
  • CYP2D6 inhibitors (bupropion, quinidine, terbinafine, paroxetine)
  • Ergot-derived drugs (methysergide, pergolide)
  • Stimulants (amphetamine, methylphenidate)
  • Decongestants (pseudoephedrine, phenylephrine) and dextromethorphan
  • Serotonin-boosting supplements (St. John's wort, 5-hydroxytryptophan, L-tryptophan)
  • Stimulant supplements with additive effects (caffeine, yohimbine, synephrine)
  • Mushroom-and-niacin "stacks" (lion's mane and niacin)
  • Full-dose psychedelics (LSD, psilocybin) and MDMA
  • Alcohol and cannabis

Risk & Side Effects

  • High: Anxiety and unpleasant subjective effects; reduced cognitive control; blood pressure increases
  • Medium: Physiological discomfort
  • Low: Psychiatric destabilization in predisposed individuals; contaminated or misidentified product; heart-valve disease; hallucinogen persisting perception disorder
  • Speculative:

Monitoring

Marker Target Why
Blood pressure (seated, resting) Below 120/80 mmHg Rose at 10-20 µg
Resting heart rate 50-70 beats per minute Rose under 15% at 10 µg; marks stimulant load
Echocardiogram (heart-valve ultrasound) No new or worsening valve regurgitation versus baseline Related drugs caused valve scarring through the serotonin 2B receptor
Electrocardiogram No established LSD-specific target; track corrected QT interval and rhythm change from baseline Used as safety measure in a patient trial
Liver enzymes (ALT, AST) ALT at or below 25 U/L LSD is cleared by liver enzymes
CYP2D6 genotype (one-time) No optimal target; note metabolizer status Poor metabolizers had about 75% higher exposure
Mood and anxiety questionnaire scores No established target; track change from own baseline (lower is better) Anxiety is the leading adverse event; tests claimed benefit
Sleep duration (wearable) 7-9 hours per night; track change from baseline The one controlled sleep signal was +24 minutes

Cadence: Baseline first; blood pressure, heart rate, mood scores and sleep at 1, 4 and 8 weeks, then every 3 months; ultrasound and liver enzymes after 6-12 months, then yearly

Qualitative Assessment

  • Sleep quality and morning refreshment
  • Daytime energy and mood stability
  • Anxiety or restlessness after dosing
  • Focus and cognitive clarity
  • Any perceptual effects (a sign the dose is too high)